I agree that this site is using cookies. You can find further informations here.
X
Escrivá-de-Romaní, Santiago
42  results:
Search for persons X
?
1

3-year invasive disease-free survival with chemotherapy de-..:

Pérez-García, José Manuel ; Cortés, Javier ; Ruiz-Borrego, Manuel...
The Lancet.  403 (2024)  10437 - p. 1649-1659 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Clinicopathological and molecular predictors of [18F]FDG-PE..:

Llombart-Cussac, Antonio ; Prat, Aleix ; Pérez-García, José Manuel...
European Journal of Nuclear Medicine and Molecular Imaging.  51 (2024)  9 - p. 2733-2743 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Treatment of mild asymptomatic cardiotoxicity in early-stag..:

Oristrell, Gerard ; Burcet, Gemma ; Valente, Filipa...
Revista Española de Cardiología (English Edition).  76 (2023)  6 - p. 480-483 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Real world data on the demographic and clinicopathological ..:

Antolín Novoa, Silvia ; Escrivá-de-Romaní, Santiago ; Tolosa Ortega, Pablo...
Cancer Treatment and Research Communications.  37 (2023)  - p. 100772 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Systemic Therapy for HER2-Positive Metastatic Breast Cancer..:

Vega Cano, Kreina Sharela ; Marmolejo Castañeda, David Humberto ; Escrivá-de-Romaní, Santiago.
Cancers.  15 (2022)  1 - p. 51 , 2022
Link: https://doi.org/10.3390/..
 
?
6

Clearance of ctDNA in triple-negative and HER2-positive bre..:

Ciriaco, Nikaoly ; Zamora, Esther ; Escrivá-de-Romaní, Santiago...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211396 , 2022
Link: https://doi.org/10.1177/..
 
?
7

Therapy-Induced Senescence Enhances the Efficacy of HER2-Ta..:

Duro-Sánchez, Santiago ; Nadal-Serrano, Mercedes ; Lalinde-Gutiérrez, Marta...
Cancer Research.  82 (2022)  24 - p. 4670-4679 , 2022
Link: https://doi.org/10.1158/..
 
?
8

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubi..:

López-Miranda, Elena ; Pérez-García, José Manuel ; Di Cosimo, Serena...
Cancers.  12 (2020)  12 - p. 3509 , 2020
Link: https://doi.org/10.3390/..
 
?
9

The Second Generation Antibody-Drug Conjugate SYD985 Overco..:

Nadal-Serrano, Mercedes ; Morancho, Beatriz ; Escrivá-de-Romaní, Santiago...
Cancers.  12 (2020)  3 - p. 670 , 2020
Link: https://doi.org/10.3390/..
 
?
10

Palbociclib and ribociclib in breast cancer: consensus work..:

Bellet, Meritxell ; Ahmad, Faten ; Villanueva, Rafael...
Therapeutic Advances in Medical Oncology.  11 (2019)  - p. 175883591983386 , 2019
Link: https://doi.org/10.1177/..
 
?
11

HER2-positive breast cancer: Current and new therapeutic st..:

Escrivá-de-Romaní, Santiago ; Arumí, Miriam ; Bellet, Meritxell.
The Breast.  39 (2018)  - p. 80-88 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Margetuximab Versus Trastuzumab in Patients With Previously..:

Rugo, Hope S ; Im, Seock-Ah ; Cardoso, Fatima...
qt5xf6t2rt.  , 2023
Link: https://escholarship.org..
 
?
13

Margetuximab Versus Trastuzumab in Patients With Previously..:

Rugo, Hope S ; Im, Seock-Ah ; Cardoso, Fatima...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839304/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Margetuximab Versus Trastuzumab in Patients With Previously..:

Rugo, Hope S ; Im, Seock-Ah ; Cardoso, Fatima...
Journal of Clinical Oncology, Vol.41 No.2, pp.198-+.  , 2023
Link: https://hdl.handle.net/1..
 
?
15

Therapy-Induced Senescence Enhances the Efficacy of HER2-Ta..:

Duro-Sánchez, Santiago ; Nadal-Serrano, Mercedes ; Lalinde-Gutiérrez, Marta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755966/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15